Matches in SemOpenAlex for { <https://semopenalex.org/work/W2044452648> ?p ?o ?g. }
- W2044452648 endingPage "7534" @default.
- W2044452648 startingPage "7520" @default.
- W2044452648 abstract "We have prepared a series of achiral aminoacetonitriles, bearing tri-ring benzamide moieties and an aminocyclohexanecarboxylate residue at P2. This combination of binding elements resulted in sub-250 pM, reversible, selective, and orally bioavailable cathepsin K inhibitors. Lead compounds displayed single digit nanomolar inhibition in vitro (of rabbit osteoclast-mediated degradation of bovine bone). The best compound in this series, 39n (CRA-013783/L-006235), was orally bioavailable in rats, with a terminal half-life of over 3 h. 39n was dosed orally in ovariectomized rhesus monkeys once per day for 7 days. Collagen breakdown products were reduced by up to 76% dose-dependently. Plasma concentrations of 39n above the bone resorption IC50 after 24 h indicated a correlation between functional cellular and in vivo assays. Inhibition of collagen breakdown by cathepsin K inhibitors suggests this mechanism of action may be useful in osteoporosis and other indications involving bone resorption." @default.
- W2044452648 created "2016-06-24" @default.
- W2044452648 creator A5002436223 @default.
- W2044452648 creator A5003106142 @default.
- W2044452648 creator A5003543491 @default.
- W2044452648 creator A5003554962 @default.
- W2044452648 creator A5003690739 @default.
- W2044452648 creator A5004599504 @default.
- W2044452648 creator A5006662504 @default.
- W2044452648 creator A5013889654 @default.
- W2044452648 creator A5024228782 @default.
- W2044452648 creator A5025021180 @default.
- W2044452648 creator A5034270512 @default.
- W2044452648 creator A5036811529 @default.
- W2044452648 creator A5036883432 @default.
- W2044452648 creator A5039666621 @default.
- W2044452648 creator A5042186052 @default.
- W2044452648 creator A5044044762 @default.
- W2044452648 creator A5045507551 @default.
- W2044452648 creator A5045576278 @default.
- W2044452648 creator A5046915476 @default.
- W2044452648 creator A5047150987 @default.
- W2044452648 creator A5047234096 @default.
- W2044452648 creator A5058476835 @default.
- W2044452648 creator A5062096250 @default.
- W2044452648 creator A5062889213 @default.
- W2044452648 creator A5063053925 @default.
- W2044452648 creator A5063518304 @default.
- W2044452648 creator A5063566841 @default.
- W2044452648 creator A5064944026 @default.
- W2044452648 creator A5073585995 @default.
- W2044452648 creator A5075131235 @default.
- W2044452648 creator A5077864982 @default.
- W2044452648 creator A5082477092 @default.
- W2044452648 creator A5091232423 @default.
- W2044452648 date "2005-10-29" @default.
- W2044452648 modified "2023-10-10" @default.
- W2044452648 title "Design and Synthesis of Tri-Ring P<sub>3</sub> Benzamide-Containing Aminonitriles as Potent, Selective, Orally Effective Inhibitors of Cathepsin K" @default.
- W2044452648 cites W1515227258 @default.
- W2044452648 cites W1964037690 @default.
- W2044452648 cites W1968333574 @default.
- W2044452648 cites W1969898994 @default.
- W2044452648 cites W1984965767 @default.
- W2044452648 cites W2009392789 @default.
- W2044452648 cites W2025062557 @default.
- W2044452648 cites W2038422579 @default.
- W2044452648 cites W2056294481 @default.
- W2044452648 cites W2078146467 @default.
- W2044452648 cites W2090177025 @default.
- W2044452648 cites W2094129456 @default.
- W2044452648 cites W2124507977 @default.
- W2044452648 cites W2137360241 @default.
- W2044452648 cites W2138922707 @default.
- W2044452648 cites W2153462664 @default.
- W2044452648 cites W2155036500 @default.
- W2044452648 cites W2181274231 @default.
- W2044452648 doi "https://doi.org/10.1021/jm058198r" @default.
- W2044452648 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16302794" @default.
- W2044452648 hasPublicationYear "2005" @default.
- W2044452648 type Work @default.
- W2044452648 sameAs 2044452648 @default.
- W2044452648 citedByCount "93" @default.
- W2044452648 countsByYear W20444526482012 @default.
- W2044452648 countsByYear W20444526482013 @default.
- W2044452648 countsByYear W20444526482014 @default.
- W2044452648 countsByYear W20444526482015 @default.
- W2044452648 countsByYear W20444526482016 @default.
- W2044452648 countsByYear W20444526482017 @default.
- W2044452648 countsByYear W20444526482018 @default.
- W2044452648 countsByYear W20444526482019 @default.
- W2044452648 countsByYear W20444526482020 @default.
- W2044452648 countsByYear W20444526482021 @default.
- W2044452648 countsByYear W20444526482022 @default.
- W2044452648 countsByYear W20444526482023 @default.
- W2044452648 crossrefType "journal-article" @default.
- W2044452648 hasAuthorship W2044452648A5002436223 @default.
- W2044452648 hasAuthorship W2044452648A5003106142 @default.
- W2044452648 hasAuthorship W2044452648A5003543491 @default.
- W2044452648 hasAuthorship W2044452648A5003554962 @default.
- W2044452648 hasAuthorship W2044452648A5003690739 @default.
- W2044452648 hasAuthorship W2044452648A5004599504 @default.
- W2044452648 hasAuthorship W2044452648A5006662504 @default.
- W2044452648 hasAuthorship W2044452648A5013889654 @default.
- W2044452648 hasAuthorship W2044452648A5024228782 @default.
- W2044452648 hasAuthorship W2044452648A5025021180 @default.
- W2044452648 hasAuthorship W2044452648A5034270512 @default.
- W2044452648 hasAuthorship W2044452648A5036811529 @default.
- W2044452648 hasAuthorship W2044452648A5036883432 @default.
- W2044452648 hasAuthorship W2044452648A5039666621 @default.
- W2044452648 hasAuthorship W2044452648A5042186052 @default.
- W2044452648 hasAuthorship W2044452648A5044044762 @default.
- W2044452648 hasAuthorship W2044452648A5045507551 @default.
- W2044452648 hasAuthorship W2044452648A5045576278 @default.
- W2044452648 hasAuthorship W2044452648A5046915476 @default.
- W2044452648 hasAuthorship W2044452648A5047150987 @default.
- W2044452648 hasAuthorship W2044452648A5047234096 @default.
- W2044452648 hasAuthorship W2044452648A5058476835 @default.
- W2044452648 hasAuthorship W2044452648A5062096250 @default.